Twenty years of agency experience in corporate communications, the last 16 spent providing strategic counsel and tactical execution to biopharma and medtech companies ranging from VC-funded startups to emerging publicly traded firms and global organizations. Fluent in the capital markets with a strong comfort level in counseling senior executives on financial communications. Equally experienced in communicating the multiple facets of biopharma and medtech stories to multiple stakeholders across the product lifecycle (i.e. pre-clinical science, registration trial progress and results, FDA interactions and communications, etc. to investors, potential partners, healthcare buyers, consumers, payers, and practitioners).